Amanote Research
Register
Sign In
Clinical Trial With a Beta-Receptor Antagonist (Propranolol) in Parkinsonism.
Journal of Neurology, Neurosurgery and Psychiatry
- United Kingdom
doi 10.1136/jnnp.28.5.404
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Neurology
Surgery
Date
October 1, 1965
Authors
R R Strang
Publisher
BMJ
Related search
The Histamine H3 Receptor Antagonist Thioperamide Rescues Circadian Rhythm and Memory Function in Experimental Parkinsonism
Translational Psychiatry
Psychiatry
Molecular Neuroscience
Biological Psychiatry
Mental Health
Cellular
Effect of Zonisamide on Parkinsonism in Patients With Dementia With Lewy Bodies: A Phase 3 Randomized Clinical Trial
Parkinsonism and Related Disorders
Gerontology
Geriatrics
Neurology
IL-1 Receptor Antagonist in Combination With Pentoxifylline and Zinc for Severe Alcoholic Hepatitis: A Multicenter Randomized Double-Bind Placebo-Controlled Clinical Trial
Hepatology
Medicine
Hepatology
Propranolol for Infants With Hemangioma: Confusion Between Beta Agonists and Beta Antagonists
Angiology: Open Access
IL-1 Beta Receptor Antagonist Efficacy in the Treatment of Idiopathic Recurrent Pericarditis
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Clinical Immunology Recombinant Human Interleukin Receptor Antagonist Influences Serum Chemokines in Patients With Rheumatoid Arthritis
Central-European Journal of Immunology
Allergy
Immunology
Phase 1 Trial of the Antiangiogenic Peptide ATN-161 (Ac-PHSCN-Nh2), a Beta Integrin Antagonist, in Patients With Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
Trial of Propranolol in Acute Myocardial Infarction.
BMJ
Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications
Current Topics in Medicinal Chemistry
Medicine
Drug Discovery
